BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9620288)

  • 1. Genetic analysis of male pattern baldness and the 5alpha-reductase genes.
    Ellis JA; Stebbing M; Harrap SB
    J Invest Dermatol; 1998 Jun; 110(6):849-53. PubMed ID: 9620288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of genetic polymorphisms of steroid 5alpha-reductase type 1 and 2 genes in Korean men with androgenetic alopecia.
    Ha SJ; Kim JS; Myung JW; Lee HJ; Kim JW
    J Dermatol Sci; 2003 Apr; 31(2):135-41. PubMed ID: 12670724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin gene polymorphism and premature male pattern baldness in the general population.
    Ellis JA; Stebbing M; Harrap SB
    Clin Sci (Lond); 1999 Jun; 96(6):659-62. PubMed ID: 10334972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of the androgen receptor gene is associated with male pattern baldness.
    Ellis JA; Stebbing M; Harrap SB
    J Invest Dermatol; 2001 Mar; 116(3):452-5. PubMed ID: 11231320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants in the 5alpha-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women.
    Goodarzi MO; Shah NA; Antoine HJ; Pall M; Guo X; Azziz R
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4085-91. PubMed ID: 16849416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
    Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
    J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical roles of testosterone and epitestosterone to 5 alpha-reductase as indicators of male-pattern baldness.
    Choi MH; Yoo YS; Chung BC
    J Invest Dermatol; 2001 Jan; 116(1):57-61. PubMed ID: 11168798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of 5α-reductase gene polymorphisms on circulating and intraprostatic androgens in prostate cancer.
    Lévesque É; Laverdière I; Lacombe L; Caron P; Rouleau M; Turcotte V; Têtu B; Fradet Y; Guillemette C
    Clin Cancer Res; 2014 Feb; 20(3):576-84. PubMed ID: 24277450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extract of Thujae occidentalis semen inhibited 5alpha-reductase and androchronogenetic alopecia of B6CBAF1/j hybrid mouse.
    Park WS; Lee CH; Lee BG; Chang IS
    J Dermatol Sci; 2003 Apr; 31(2):91-8. PubMed ID: 12670719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia.
    Hayes VM; Severi G; Padilla EJ; Morris HA; Tilley WD; Southey MC; English DR; Sutherland RL; Hopper JL; Boyle P; Giles GG
    Int J Cancer; 2007 Feb; 120(4):776-80. PubMed ID: 17136762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of genetic variants in the two isoforms of 5α-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome.
    Graupp M; Wehr E; Schweighofer N; Pieber TR; Obermayer-Pietsch B
    Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):175-9. PubMed ID: 21530059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of polymorphisms in the SRD5A2 gene and semen parameters in Estonian men.
    Peters M; Saare M; Kaart T; Haller-Kikkatalo K; Lend AK; Punab M; Metspalu A; Salumets A
    J Androl; 2010; 31(4):372-8. PubMed ID: 19926884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
    Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
    Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1.
    Ellis JA; Panagiotopoulos S; Akdeniz A; Jerums G; Harrap SB
    J Hum Genet; 2005; 50(10):534-537. PubMed ID: 16155734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient expression of the 5alpha-reductase type 2 isozyme in the rat brain in late fetal and early postnatal life.
    Poletti A; Negri-Cesi P; Rabuffetti M; Colciago A; Celotti F; Martini L
    Endocrinology; 1998 Apr; 139(4):2171-8. PubMed ID: 9529007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
    Ryu HK; Kim KM; Yoo EA; Sim WY; Chung BC
    Br J Dermatol; 2006 Apr; 154(4):730-4. PubMed ID: 16536818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients.
    Maimoun L; Philibert P; Cammas B; Audran F; Bouchard P; Fenichel P; Cartigny M; Pienkowski C; Polak M; Skordis N; Mazen I; Ocal G; Berberoglu M; Reynaud R; Baumann C; Cabrol S; Simon D; Kayemba-Kay's K; De Kerdanet M; Kurtz F; Leheup B; Heinrichs C; Tenoutasse S; Van Vliet G; Grüters A; Eunice M; Ammini AC; Hafez M; Hochberg Z; Einaudi S; Al Mawlawi H; Nuñez CJ; Servant N; Lumbroso S; Paris F; Sultan C
    J Clin Endocrinol Metab; 2011 Feb; 96(2):296-307. PubMed ID: 21147889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
    Dallob AL; Sadick NS; Unger W; Lipert S; Geissler LA; Gregoire SL; Nguyen HH; Moore EC; Tanaka WK
    J Clin Endocrinol Metab; 1994 Sep; 79(3):703-6. PubMed ID: 8077349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minoxidil increases 17 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase activity of cultured human dermal papilla cells from balding scalp.
    Sato T; Tadokoro T; Sonoda T; Asada Y; Itami S; Takayasu S
    J Dermatol Sci; 1999 Feb; 19(2):123-5. PubMed ID: 10098703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.